MeSH tree: D03.633.100.759.590.138.325
Two major Australian health insurers, Bupa and Medibank, have started offering genetic testing meant to tell you your likely reaction to certain medications.
Oct 1, 2025
0
13
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international ...
Jul 23, 2024
0
58
Although medications can often help patients find a cure or respite from their condition, millions of people worldwide suffer from unpredictable drug toxicities every year. In particular, drug eruptions which manifest through ...
May 15, 2024
0
31
Multiple sclerosis (MS) is a disease that looks different in everyone who has it—and you may know more people who have it than you think.
Mar 5, 2024
0
40
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
Aug 2, 2023
0
109
Post-surgical radiotherapy and temozolomide, a chemotherapeutic drug, targeting post-cell division is the current standard of care for glioblastoma (GBM)—the most prevalent and lethal primary tumor of the central nervous ...
Jan 18, 2023
0
52
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
99
A new research paper titled "Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma" has been published in Oncotarget.
Dec 13, 2022
0
44
Monash University researchers have used the world's largest multiple sclerosis (MS) registry, MSBase, to provide evidence that will help those with MS take the best medicine for them.
Nov 7, 2022
0
53
